News - International Congress Pharma Uzbekistan & Central Asia

+44 207 394 30 90 (London)

Authoritative platform of market leaders for the exchange of knowledge and experience in the pharmaceutical field

About the Congress
Сonditions of Participation
Speakers
Investment Projects
Participants
Programme
Insights
Sponsorship
Media Partners
Venue
Contact Us
Previous events

☰

Supported by:

About the Congress
Сonditions of Participation
Speakers
Investment Projects
Participants
Programme
Insights
Sponsorship
Media Partners
Venue
Contact Us
Previous events

+44 207 394 30 90 (London)

events@vostockcapital.com

www.vostockcapital.com

supported by Inventica

Copyright © 2026 - Vostock Capital UK

Terms and Conditions of Website Use
Privacy Policy and Cookie Policy for Website

About the Congress
Сonditions of Participation
Speakers
Investment Projects
Participants
Programme
Insights
Sponsorship
Media Partners
Venue
Contact Us
Previous events

en_US

Full Name

Company

Job title

Mobile phone

Work email

Promo Code

Please note that due to our internal policy we are not entitled to send any materials to personal emails (Yahoo, Yandex, Google, etc.)

If you have any questions, please contact us:

+44 207 394 3090 (London)

Where did you hear about this event?

Online journal, portalPrint mediaSocial mediaInternetE-shotRecommendation

Other

I agree to the terms of the User Agreement and consent to the processing and storage of my personal data in accordance with the Privacy Policy*

By registering, you agree to the terms of participation

DISCLAIMER

The company takes reasonable measures to ensure the accuracy and timeliness of the content but does not assume responsibility for actions taken by third parties based on the information, whether provided by the company or third parties.

The information, opinions, and evaluations contained in the document are not intended for distribution or use by any individual or legal entity in any jurisdiction where it would contravene the law or regulations or require registration or licensing.

The company does not claim that the provided information or opinions are true at all times or comprehensive, but they are based on data obtained from reliable sources. The presented information should not be used as the sole guide for making investment decisions.